ClinicalTrials.Veeva

Menu

Turkish Adaptation and Psychometric Properties of Fugl-Meyer Assessment in Acute Stroke Patients (FMD)

I

Istanbul University - Cerrahpasa (IUC)

Status

Enrolling

Conditions

Stroke, Acute
Cerebrovascular; Disorder, Acute

Study type

Observational

Funder types

Other

Identifiers

NCT05823298
FMA Acute Stroke

Details and patient eligibility

About

The aim of this methodological study is to adapt the Fugl-Meyer assessment to Turkish culture and to test its validity and reliability in acute phase stroke patients.

Full description

According to the definition of the World Health Organization, stroke is a clinical syndrome that causes rapid focal (or global) cerebral function loss for no apparent reason other than vascular causes, and symptoms persist for more than 24 hours or lead to death.

To effectively manage the post-stroke processes and establish an effective treatment plan, a comprehensive assessment is necessary. One of the most common motor problems following a stroke is hemiplegia, which makes it challenging for the patient to perform activities of daily living and ambulation. Understanding the mechanisms of motor control and motor learning, which are vital components of stroke rehabilitation, necessitates the assessment of motor function. For evaluating motor function in stroke patients, there are numerous outcome measures available. The Fugl-Meyer Assessment (FMA) stands out when comparison of these assessments in terms of clinical and psychometric values. There is no official FMA version that has been translated into Turkish, even though Fugl-Meyer assessment is used in numerous research in Turkey. The aim of this study is to adapt the Fugl-Meyer assessment to Turkish culture and to test its validity and reliability in acute stroke patients.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who diagnosed with stroke
  • Less than 1 month passed after onset of stroke
  • Upper and lower extremity motor involvement between Brunnstrom stages 2 and 5
  • Voluntarily accepting to participate in this research

Exclusion criteria

  • Visual and hearing impairment
  • Upper or lower extremity amputation
  • Significant cognitive impairment (Mini Mental State Test Score < 18)
  • Mental disorders affecting daily life functioning
  • Global aphasia
  • Other unstable conditions that may affect participation

Trial contacts and locations

1

Loading...

Central trial contact

Ceren Bayrak, 3; Lide Z Uz, 1

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems